Shijiazhuang Yiling Pharmaceutical Co., Ltd.
002603
Rank in Stocks
#4276
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and... Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfection products, personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
Share Price
$2.24
Market Cap
$3.75B
Change (1 day)
0.85%
Change (1 year)
-8.39%
Country
CN
Trade Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
Category
Healthcare
Earnings for Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
Earnings in Jun 2026 TTM: $246.26M
According to Shijiazhuang Yiling Pharmaceutical Co., Ltd. latest financial reports the company's current earnings are $246.26M. In 2023 the company made an earning of $237.93M, a decrease compared to its 2022 earnings that were of $403.11M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Shijiazhuang Yiling Pharmaceutical Co., Ltd. from 2008 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $246.26M | -324.63% |
| 2024 | $-109.63M | -146.08% |
| 2023 | $237.93M | -40.98% |
| 2022 | $403.11M | 64.90% |
| 2021 | $244.45M | 12.26% |
| 2020 | $217.75M | 114.19% |
| 2019 | $101.66M | -0.25% |
| 2018 | $101.91M | 3.87% |
| 2017 | $98.11M | 8.63% |
| 2016 | $90.32M | 17.44% |
| 2015 | $76.90M | 16.02% |
| 2014 | $66.28M | 38.96% |
| 2013 | $47.70M | 37.56% |
| 2012 | $34.68M | -58.95% |
| 2011 | $84.47M | 51.19% |
| 2010 | $55.87M | 7.65% |
| 2009 | $51.90M | 145.52% |
| 2008 | $21.14M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $1.35B | 448.16% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $26.37M | -89.29% |
US
|
